期刊文献+

眼镜蛇毒因子抑制脓毒症大鼠的炎症反应 被引量:3

Cobra venom factor inhibites inflammatory responses of septic rats
下载PDF
导出
摘要 目的观察补体抑制剂眼镜蛇毒因子(CVF)对脓毒症大鼠血清细胞因子释放的影响及对肺组织的保护作用。方法144只清洁雄性SD大鼠(体重250~300g)随机分为A、B、C3组,每组48只。A组假手术组,B组(脓毒症组)采用盲肠结扎穿孔术(CLP)复制脓毒症大鼠模型,C组(CVF组)在盲肠结扎穿孔术前24h按50μg/kg注射CVF,A和B组给予等量生理盐水。于术后6个时间点分别采用放射免疫分析法和酶联免疫吸附法检测血清TNF-α、IL-6和IL-10水平,肺组织MPO含量及病理学改变。结果B组大鼠脓毒症反应最强,A组表现轻微;B组TNF-α及IL-6水平均明显高于A组(P<0.05,P<0.01);B组除2h点外,肺组织MPO水平显著高于A组(P<0.05,P<0.01);B组肺组织损伤最严重;C组经CVF干预后脓毒症反应及肺组织损伤较B组明显减轻,TNF-α、IL-6及MPO水平均较B组明显下降(P<0.05,P<0.01)。结论补体抑制剂CVF可减轻脓毒症大鼠的炎症反应,具有肺保护作用。 Objective To investigate the effects on release of serum cytokines and protection of lung tissues by inhibiting complement activation with cobra venom factor (CVF). Methods One hundred and 44 SD rats ( clean, male ,250 -300 g) were randomly divided into three groups (each n = 48 ) :group A (sham group) ; group B (sepsis group) in which sepsis was induced by cecal ligation and puncture (CLP); group C( CVF pretreatment):sepsis was induced by CLP after pretreatment with CVF, rats were given a dose of 50 μg/kg CVF before operation, an equal volume of saline solution in group A and group B. MPO contents, level of TNF-α,IL-6 and IL-10 were measured at 6 hours points. Lung tissues were observed for change of histopathology. Results The manifestations of sepsis were more severe in group B than that of group A. The level of TNF-α and IL-6 was higher in group B than that of group A ( P 〈 0.05, P 〈 0. 01 ). MPO content of lung tissues was higher in group B than that of group A (P 〈0. 05 ,P 〈0. 01 ). Histological damage was much severe in group B than in group A. However, after injection CVF in group C, the manifestations of sepsis were much lighter and the levels of TNF-α, IL-6 and MPO were decreased obviously (P 〈0. 05 ,P 〈0. 01 ). The histologic damage ameliorated in CVF group as compared to that of group B. Conclusion CVF alleviates the systemic inflammatory response and provide protection to lung tissue of septic rats.
出处 《基础医学与临床》 CSCD 北大核心 2008年第11期1178-1182,共5页 Basic and Clinical Medicine
基金 江西省自然科学基金(0440083)
关键词 脓毒症 补体 眼镜蛇毒因子 炎症反应 sepsis complement cobra venom factor inflammatory responses
  • 相关文献

参考文献10

  • 1Tsiotou AG, Sakorafas GH, Anagnostopoulos G,et al. Septic shock:current pathogenetic concepts from a clinical perspective [ J ]. Med Sci Monit, 2005, 11 (3) : RAT6 - 85.
  • 2Flierl MA,Schreiber H, Huber-Lang MS. The role of complement,CSa and its receptors in sepsis and multiorgan dysfunction syndrome[J]. J Invest Surg, 2006, 19(4):255 - 265.
  • 3Mizuno M, Nishikawa K, Okada N, et al. Soluble complement receptor type 1 protects rats from lethal shock induced by anti-Crry antibody following lipopolysaccharide priming [J]. Int Arch Allergy Immunol, 2002, 127(1) :55 -62.
  • 4朱雪琦,刘清泉,姚咏明.脓毒症动物模型制备方法的研究进展[J].中国危重病急救医学,2006,18(2):114-116. 被引量:30
  • 5Haas PJ, van Strijp J. Anaphylatoxins: their role in bacterial infection and inflammation [ J ]. Immunol Res, 2007, 37 (3) :161 -175.
  • 6Hietbrink F, Koenderman L, Rijkers G, et al. Trauma: the role of the innate immune system[ J]. World J Emerg Surg, 2006, 20(5)1:15.
  • 7Philippart F, Cavaillon JM. Sepsis mediators [ J ]. Curr Infect Dis Rep, 2007, 9(5) : 358 -365.
  • 8Hopken U, Mohr M, Struber A, et al. Inhibition of interleu- kin-6 synthesis in an animal model of septic shock by anti- C5a monoclonal antibodies[ J]. Eur J Immunol, 1996, 26 (5) :1103 - 1109.
  • 9Mohr M, Hopken U, Oppermann M, et al. Effects of anti- C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis [J]. Eur J Clin Invest, 1998, 28 (3): 227 - 234.
  • 10Mizuno M, Morgan BP. The possibilities and pitfalls for anti-complement therapies in inflammatory diseases[ J]. Curt Drug Targets Inflamm Allergy, 2004, 3 ( 1 ) : 87 - 96.

二级参考文献20

  • 1姚咏明,盛志勇.内毒素与革兰阳性菌致病因子的协同效应与意义[J].中国危重病急救医学,2005,17(4):193-196. 被引量:13
  • 2Schultz M J,van der Poll T.Animal and human models for sepsis[J].Ann Med,2002,34:573-581.
  • 3Mathiak G,Szewczyk D,Abduah F,et al.An improved clinically relevant sepsis model in the conscious rat[J].Crit Care Med,2000,28:1947-1952.
  • 4Sewnath M E,Olszyna D P,Birjmohun R,et al.IL-10-deficient mice demonstrate multipe organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance[J].J Immunol,2001,166:6323-6331.
  • 5胡森 盛志勇 胡森.MODS动物模型[M].盛志勇,胡森.多器官功能障碍综合征[C].北京:科学出版社,1999.185-199.
  • 6Corral J,Yelamos J,Hernandez-Espinosa D,et al.Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models [J].Am J Pathol,2005,166:1089-1098.
  • 7Remick D G,Bolgos G,Copeland S,et al.Role of interleukin-6 in mortality from and physiologic response to sepsis[J].Infect Immun,2005,73:2751-2757.
  • 8Zell Weger R,Wichmann M W,Ayala A,et al.Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males[J].Crit Care Med,1997,25:106-110
  • 9Wichmann M,Zellweger R,De Maso C M,et al.Chaudry IH:mechanism of immune suppression in males following trauma-hemorrhage:critical role of testosterone[J].Arch Surg,1996,131:1186-1192.
  • 10Deitch E A.Animal models of sepsis and shock:a review and lessons learned[J].Shock,1998,9:1-11.

共引文献29

同被引文献24

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部